96 related articles for article (PubMed ID: 20599838)
1. GABA(A) receptor density is altered by cannabinoid treatment in the hippocampus of adult but not adolescent rats.
Verdurand M; Dalton VS; Zavitsanou K
Brain Res; 2010 Sep; 1351():238-245. PubMed ID: 20599838
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats.
Zavitsanou K; Wang H; Dalton VS; Nguyen V
Neuroscience; 2010 Aug; 169(1):315-24. PubMed ID: 20438810
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.
Dalton VS; Zavitsanou K
Synapse; 2010 Nov; 64(11):845-54. PubMed ID: 20842718
[TBL] [Abstract][Full Text] [Related]
4. Differential treatment regimen-related effects of cannabinoids on D1 and D2 receptors in adolescent and adult rat brain.
Dalton VS; Zavitsanou K
J Chem Neuroanat; 2010 Dec; 40(4):272-80. PubMed ID: 20673846
[TBL] [Abstract][Full Text] [Related]
5. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Robinson L; Goonawardena AV; Pertwee RG; Hampson RE; Riedel G
Br J Pharmacol; 2007 Jul; 151(5):688-700. PubMed ID: 17502849
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.
Jiang W; Zhang Y; Xiao L; Van Cleemput J; Ji SP; Bai G; Zhang X
J Clin Invest; 2005 Nov; 115(11):3104-16. PubMed ID: 16224541
[TBL] [Abstract][Full Text] [Related]
7. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.
Cheer JF; Marsden CA; Kendall DA; Mason R
Neuroscience; 2000; 99(4):661-7. PubMed ID: 10974429
[TBL] [Abstract][Full Text] [Related]
8. HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.
Dalton VS; Wang H; Zavitsanou K
Neurochem Res; 2009 Jul; 34(7):1343-53. PubMed ID: 19169813
[TBL] [Abstract][Full Text] [Related]
9. Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging.
Shah YB; Prior MJ; Dixon AL; Morris PG; Marsden CA
Neuropharmacology; 2004 Mar; 46(3):379-87. PubMed ID: 14975693
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of GABA A receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats.
Kang-Park MH; Wilson WA; Kuhn CM; Moore SD; Swartzwelder HS
J Neurophysiol; 2007 Sep; 98(3):1223-30. PubMed ID: 17634345
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure.
Higuera-Matas A; Miguéns M; Coria SM; Assis MA; Borcel E; del Olmo N; Ambrosio E
Neuropharmacology; 2012 Apr; 62(5-6):1975-84. PubMed ID: 22245681
[TBL] [Abstract][Full Text] [Related]
12. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
13. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
Alsalem M; Haddad M; Aldossary SA; Kalbouneh H; Altarifi A; Jaffal SM; Abbas MA; Aldaoud N; El-Salem K
Inflammopharmacology; 2019 Dec; 27(6):1131-1142. PubMed ID: 30945071
[TBL] [Abstract][Full Text] [Related]
14. Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats.
Chapman V
Neuropharmacology; 2001 Dec; 41(7):870-7. PubMed ID: 11684151
[TBL] [Abstract][Full Text] [Related]
15. Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG.
Nguyen VH; Verdurand M; Dedeurwaerdere S; Wang H; Zahra D; Gregoire MC; Zavitsanou K
Brain Res Bull; 2012 Feb; 87(2-3):172-9. PubMed ID: 22155282
[TBL] [Abstract][Full Text] [Related]
16. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V
Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347
[TBL] [Abstract][Full Text] [Related]
17. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
Breivogel CS; Scates SM; Beletskaya IO; Lowery OB; Aceto MD; Martin BR
Eur J Pharmacol; 2003 Jan; 459(2-3):139-50. PubMed ID: 12524139
[TBL] [Abstract][Full Text] [Related]
18. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
Millns PJ; Chapman V; Kendall DA
Br J Pharmacol; 2001 Mar; 132(5):969-71. PubMed ID: 11226126
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
Ralevic V; Kendall DA
Eur J Pharmacol; 2001 Apr; 418(1-2):117-25. PubMed ID: 11334873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
